Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-02-28 @ 8:50 PM
Study NCT ID:
NCT03272334
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-27
First Post:
2017-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
Sponsor:
Organization: